BioCentury
ARTICLE | Clinical News

Derivatives of Arglabin farnesyl transferase inhibitor regulatory update

July 31, 2000 7:00 AM UTC

NLAB's Paracure Inc. subsidiary received U.S. Patent No. 6,080,741 covering its dmae-Arglabin, bae-Arglabin and mae-Arglabin phosphosesquiterpene compounds and their use to treat various cancers. ...